Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Accounts Payable & Accrued Expense : د.إ359 Mil (As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is Gulf Pharmaceutical Industries PSC Accounts Payable & Accrued Expense?

Gulf Pharmaceutical Industries PSC's quarterly accounts payable & accrued expense declined from Jun. 2023 (د.إ515 Mil) to Sep. 2023 (د.إ449 Mil) and declined from Sep. 2023 (د.إ449 Mil) to Dec. 2023 (د.إ359 Mil).

Gulf Pharmaceutical Industries PSC's annual accounts payable & accrued expense declined from Dec. 2021 (د.إ437 Mil) to Dec. 2022 (د.إ414 Mil) and declined from Dec. 2022 (د.إ414 Mil) to Dec. 2023 (د.إ359 Mil).

Gulf Pharmaceutical Industries PSC Accounts Payable & Accrued Expense Historical Data

The historical data trend for Gulf Pharmaceutical Industries PSC's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gulf Pharmaceutical Industries PSC Accounts Payable & Accrued Expense Chart

Gulf Pharmaceutical Industries PSC Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

294.10

300.20

437.20

413.90

358.50

Gulf Pharmaceutical Industries PSC Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															413.90	526.90	515.20	448.50	358.50

Gulf Pharmaceutical Industries PSC Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Airport Road, P.O. Box 997, Digdaga, Ras Al Khaimah, ARE

Website

https://www.julphar.net

Gulf Pharmaceutical Industries PSC is a generic pharmaceutical manufacturer in the Middle East and North Africa. The company manufactures and sells pharmaceuticals and medical compounds, including cosmetics compounds, and drugs. It operates in four segments: Manufacturing, Planet, Investments, and others. It maintains a diverse product portfolio that targets various therapeutic segments including Gastrointestinal Tract (GIT), Respiratory, Pain Management, Wounds & Scars, Anti-infectives, Anemia, Gynecology, Dermatology, Erectile Dysfunction, and Cardiology. The geographical segments are UAE, Other GCC countries, and Other countries.

Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Headlines

No Headlines